Curcumin for the clinical treatment of inflammatory bowel diseases: a systematic review and meta-analysis of placebo-controlled randomized clinical trials
IntroductionInflammatory Bowel Disease (IBD), encompassing Crohn disease (CD) and ulcerative colitis (UC), presents complex challenges in management due to dysregulated immune responses and genetic predispositions. This study explored the potential of curcumin as an adjunctive therapy in IBD, assess...
Saved in:
| Main Authors: | Saeid Mohseni, Ali Tavakoli, Hamid Ghazipoor, Neda Pouralimohamadi, Roghayeh Zare, Thomas Rampp, Maryam Shayesteh, Mehdi Pasalar |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-03-01
|
| Series: | Frontiers in Nutrition |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fnut.2025.1494351/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A Randomized Double‐Blind, Placebo‐Controlled Trial of Artesunate and Curcumin in Patients With Crohn's Disease: A Pilot Study
by: Devinder Kumar, et al.
Published: (2025-07-01) -
Therapeutic Potential of Curcumin and Novel Formulations in Psoriasis Treatment: Evidence and Future Prospects
by: Kantasa T, et al.
Published: (2025-06-01) -
Clinical features, treatment, and prognosis of secukinumab-induced inflammatory bowel disease
by: Ronghui Li, et al.
Published: (2025-01-01) -
Antioxidant Therapy in Inflammatory Bowel Diseases: How Far Have We Come and How Close Are We?
by: Lylian Ellen Militão dos Santos Xavier, et al.
Published: (2024-11-01) -
Clinical course of inflammatory bowel diseases in patients of the Tomsk region
by: I. A. Koinova, et al.
Published: (2021-06-01)